| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amneal Pharmaceuticals, Inc. (AMRX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. AMRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 291.0K | $4.72M | - | |
| Dir | 225.4K | $3.66M | - | |
| VP | 152.4K | $2.47M | - | |
| VP | 146.4K | $2.38M | - | |
| CFO | 122.2K | $1.98M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Alva Emily Peterson | Director | Sell | 80,000 | $8.90 | $712,000.00 | -31.9% | -16.9% | +47.9% | |
| Mar 3, 2025 | Patel Gautam | Director | Sell | 80,000 | $8.90 | $712,000.00 | -4.2% | -15.3% | +52.1% | |
| Feb 3, 2025 | Patel Gautam | Director | Sell | 80,000 | $8.14 | $651,200.00 | -4.1% | -7.8% | +74.2% | |
| Jan 8, 2025 | Patel Gautam | Director | Sell | 62,590 | $8.01 | $501,345.90 | -3.1% | -13.3% | +63.8% | |
| Jan 2, 2025 | Patel Gautam | Director | Sell | 17,410 | $8.01 | $139,454.10 | -0.8% | +5.3% | +63.1% | |
| Nov 22, 2024 | Kiely John | Director | Sale+OE | 17,058 | $8.38 | $142,946.04 | -6.0% | -6.2% | +42.4% | |
| Nov 22, 2024 | Autor Deborah M. | Director | Sell | 40,000 | $8.35 | $334,073.97 | -22.2% | -6.2% | +42.4% | |
| Nov 21, 2024 | Daly Jason B. | SVP, Chief Legal Officer | Sell | 13,665 | $8.40 | $114,786.00 | -100% | -5.6% | +43.6% | |
| Nov 15, 2024 | Daly Jason B. | SVP, Chief Legal Officer | Sell | 43,657 | $8.61 | $375,886.77 | -76.2% | -6.6% | +37.4% | |
| Aug 15, 2024 | Boyer Andrew S | Executive Vice President | Sell | 62,711 | $7.84 | $491,381.91 | -10.2% | +14.2% | +19.5% |